Inventor
MURPHY BARBARA
US14 patents
⚠️ This page may combine multiple inventors who share the name “MURPHY BARBARA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICAHN SCHOOL MED MOUNT SINAI
11 patentsUS10787709B2Sep 29, 2020
Methods for diagnosing risk of renal allograft fibrosis and rejection
ICAHN SCHOOL MED MOUNT SINAI3 citations72
US10308985B2Jun 4, 2019
Methods for diagnosing risk of renal allograft fibrosis and rejection
ICAHN SCHOOL MED MOUNT SINAI3 citations72
US10941446B2Mar 9, 2021
Method for identifying kidney allograft recipients at risk for chronic injury
ICAHN SCHOOL MED MOUNT SINAI4 citations67
US11572587B2Feb 7, 2023
Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets
ICAHN SCHOOL MED MOUNT SINAI0 citations61
US11572589B2Feb 7, 2023
Method for prediction of acute rejection and renal allograft loss using pre-transplant transcriptomic signatures in recipient blood
ICAHN SCHOOL MED MOUNT SINAI1 citations61
US11674181B2Jun 13, 2023
Method for identifying kidney allograft recipients at risk for chronic injury
ICAHN SCHOOL MED MOUNT SINAI0 citations59
US12441746B2Oct 14, 2025
HCK inhibitors for the treatment of fibrosis and cancer
ICAHN SCHOOL MED MOUNT SINAI0 citations56
US11098361B2Aug 24, 2021
Use of SHROOM3 in chronic kidney disease and chronic allograft nephropathy
ICAHN SCHOOL MED MOUNT SINAI0 citations53
US10725026B2Jul 28, 2020
Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
ICAHN SCHOOL MED MOUNT SINAI0 citations48
US9816985B2Nov 14, 2017
Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
ICAHN SCHOOL MED MOUNT SINAI0 citations48
US12378235B2Aug 5, 2025
HCK inhibitors for the treatment of fibrosis and cancer
ICAHN SCHOOL MED MOUNT SINAI0 citations45